Your browser doesn't support javascript.
loading
Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months.
Merdrignac, Lore; Acosta, Lesly; Habington, Adele; Garcìa Cenoz, Manuel; Pandolfi, Elisabetta; Fabiánová, Katerina; Jordan, Iolanda; O'Sullivan, Niam; Navasués, Ana; Tozzi, Alberto E; Zavadilová, Jana; Jané, Mireia; Cotter, Suzanne; Pitillas, Nerea I; Rizzo, Caterina; Krízová, Pavla; Hanslik, Thomas; Muñoz Almagro, Carmen; Pastore, Lucia; Bacci, Sabrina; Moren, Alain; Valenciano, Marta.
Afiliação
  • Merdrignac L; Epidemiology Department, Epiconcept, Paris, France. Electronic address: l.merdrignac@epiconcept.fr.
  • Acosta L; Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain; Universitat Politècnica de Catalunya- BarcelonaTech (UPC), Barcelona, Spain.
  • Habington A; Children's Health Ireland, Crumlin, Dublin, Ireland.
  • Garcìa Cenoz M; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain.
  • Pandolfi E; Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children Hospital, Rome, Italy.
  • Fabiánová K; National Institute of Public Health, Prague, Czech Republic.
  • Jordan I; Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; University of Barcelona, Barcelona, Spain.
  • O'Sullivan N; Children's Health Ireland, Crumlin, Dublin, Ireland.
  • Navasués A; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain.
  • Tozzi AE; Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children Hospital, Rome, Italy.
  • Zavadilová J; National Institute of Public Health, Prague, Czech Republic.
  • Jané M; Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; University of Barcelona, Barcelona, Spain.
  • Cotter S; Health Protection Surveillance Centre, Dublin, Ireland.
  • Pitillas NI; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain.
  • Rizzo C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Krízová P; National Institute of Public Health, Prague, Czech Republic.
  • Hanslik T; Sorbonne University, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Muñoz Almagro C; Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; Medicine Department, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Pastore L; European Centre for Diseases Control and Prevention, Stockholm, Sweden.
  • Bacci S; European Centre for Diseases Control and Prevention, Stockholm, Sweden.
  • Moren A; Epidemiology Department, Epiconcept, Paris, France.
  • Valenciano M; Epidemiology Department, Epiconcept, Paris, France.
Vaccine ; 40(44): 6374-6382, 2022 10 19.
Article em En | MEDLINE | ID: mdl-36182617
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coqueluche Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coqueluche Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article